GenMark Diagnostics Profile

6.75
USD 0.04  0.59%
48%
14%

GenMark Diagnostics exotic insider transaction detected

GenMark Diagnostics insider trading alert for general transaction of common stock by Scott Mendel, Chief Financial Officer, on July 1, 2018. This event was filed by Genmark Diagnostics Inc with SEC on 2017-02-24. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

GenMark Diagnostics Summary

GenMark Diagnostics (GNMK) is traded on BATS Exchange in USA. It is located in CALIFORNIA U.S.A and employs 517 people. GenMark Diagnostics is listed under Medical Equipment category by Fama And French industry classification.The company currently falls under 'Small-Cap' category with current market capitalization of 391.21 M. GenMark Diagnostics conducts business under Healthcare sector and is part of Medical Equipment industry. This company has 55.41 M outstanding shares of which 6.36 M shares are currently shorted by private and institutional investors with about 22.69 trading days to cover. GenMark Diagnosti currently holds about 65.46 M in cash with (43.91 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.18.
Check GenMark Diagnostics Probability Of Bankruptcy

Ownership Allocation (%)

Target Price Odds Analysis

Odds Below 6.75HorizonTargetOdds Above 6.75
38.01%30 days 6.75 61.69%
Based on normal probability distribution, the odds of GenMark Diagnostics to move above current price in 30 days from now is about 61.69% (This GenMark Diagnostics probability density function shows the probability of GenMark Diagnostics Stock to fall within a particular range of prices over 30 days) .

Top Holders

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Mesirow Financial Investment Management IncCommon Shares35.6 K227 K
Fox Run Management LlcCommon Shares26.4 K168 K
View GenMark Diagnostics Diagnostics

Selected GenMark Diagnostics Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

GenMark Diagnostics Against Markets

Risk Adjusted
Performance Score (0 to 100)
1 
Chance of
Financial Distress (0 to 100%)
37 
Equity ratings for GenMark Diagnostics are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
GenMark Diagnostics, Inc., a molecular diagnostics company, develops and commercializes molecular tests based on its proprietary eSensor electrochemical detection technology. GenMark Diagnostics, Inc. is headquartered in Carlsbad, California. GenMark Diagnostics operates under Medical Devices classification in USA and traded on BATS Exchange. It employs 517 people. more
Fama & French Medical Equipment
Medical Equipment
Fama & French Classification
GenMark Diagnostics SEC Filings
GenMark Diagnostics SEC Filings
Security & Exchange Commission EDGAR ReportsView All
NameGenMark Diagnostics
CEO and President and DirectorHany MassaranyView All
Thematic Classification
Currently Active Investing Idea
  Medical Equipment
View All
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Specialization
Healthcare, Medical Devices
InstrumentUSA Stock View All
RegionNorth America
LocationCALIFORNIA U.S.A
Business Address5964 La Place Court
ExchangeBATS Exchange
CIK Number0001487371
CUSIP372309104
SectorHealthcare
IndustryMedical Equipment
BenchmarkDOW
Websitewww.genmarkdx.com
Phone760 448 4300
CurrencyUSD - US Dollar

GenMark Diagnostics Corporate Directors

Kevin OBoyle Independent Director
James Fox Independent Director
Michael Kagnoff Director
Please also check Risk vs Return Analysis. Please also try Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
vendors/bower_components/jquery.easy-pie-chart/dist/jquery.easypiechart.min.js">